Montesinos, P., Cheong, J., Daver, N. G., Fathi, A., Levis, M. J., Luger, S. M., Miyamoto, T., Oliva, E. N., Perl, A. E., Récher, C., Schlenk, R. F., Wang, J., Zeidan, A. M., Liu, L., Duong, Y., Imadalou, K., Alexis, K., Nahar, A., Burns, K., Erba, H. P. (2025). QuANTUM-Wild: A phase 3, randomized, double-blind, placebo-controlled trial of quizartinib in combination with chemotherapy and as single-agent maintenance in
            <i>FLT3</i>
            -ITD–negative acute myeloid leukemia (AML).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps6580